Beck Brachman, PhD | Cofounder & CEO
Beck Brachman, PhD, is cofounder & CEO at IMPRINT. Beck has over a decade of scientific leadership experience and has worked across academia, government, and industry. Beck is best known for her pioneering work establishing the field of preventative psychopharmacology: she discovered alexigents, the first drugs that enhance stress resilience and may prevent PTSD and depression, and demonstrated that immune cells carry a memory of psychological stress. She has also worked on novel social finance instruments to incentivize public good, particularly for high-impact scientific research and generic drug repurposing. Beck obtained her PhD in Neuroscience from Columbia University and was a research fellow at the NIH. She is a 2024 SpecTech BRAINS Fellow, 2022 Convergent Research Innovation Fellow, 2019 Cornell Tech Runway Fellow, 2017 TED Fellow, 2017 NYCEDC Entrepreneurship Lab Fellow, Helena Brain Trust member, and was shortlisted for the 2024 David Prize. Her academic research has been featured in numerous media outlets, including The Atlantic, WIRED, Business Insider, and described by NPR as a "moonshot project that is very much needed in the mental health arena."
Victor Greiff, PhD | Cofounder & CTO
Victor Greiff is cofounder & Chief Technology Officer at IMPRINT. He has 15 years of expertise in developing machine learning, computational, and experimental tools for analyzing antibody and T cell repertoires, with a focus on facilitating in silico design of immune receptor-based diagnostics and therapeutics. A thought leader in the AI immune repertoire space, Dr. Greiff has co-authored over 90 papers, collaborates widely across industry and academia, has previously served as the Chair of the AIRR Community, and serves on the boards of numerous antibody companies. Dr. Greiff is also a Professor of Systems Immunology at the University of Oslo (Department of Immunology). He earned his Ph.D. from Humboldt University Berlin, Germany, and conducted postdoctoral research in the laboratory of Sai T. Reddy at ETH Zürich, Switzerland. In 2023, he was awarded a prestigious European Research Council (ERC) Consolidator Grant - among Europe’s most competitive research awards - to develop computational approaches for deciphering the antigen-specific language of adaptive immunity.
Corinna Calhoun | COO
Corinna Calhoun is Chief Operating Officer at IMPRINT, where she leads operations across U.S. and European teams, supporting the company’s growth in AI-powered forensic immunology. Corinna has shaped multi-billion-dollar businesses and high-impact scientific ventures through more than 20 years of executive leadership across biotech, nonprofit, and Fortune 50 tech sectors. She is best known for driving operational excellence and organizational health at scale - leading strategic planning, financial management, and cross-functional execution at companies including Microsoft and Amazon. Corinna has also advised mission-driven startups on systems design and organizational growth. She holds a BA from Barnard College and an MS in Organization Development from Pepperdine University.
William Hepworth | CFO
William Hepworth is the Chief Financial Officer at Imprint. He has 11 years experience investing and forming technology enterprises. He has worked in private equity and venture capital, most notably at K1, focused on growing software companies, and at GIC (Singapore’s sovereign wealth fund), where he worked on launching radical technology initiatives in asset management, including using machine learning and AI across public and private assets. He holds an undergraduate degree from Oxford University.
